Trial Profile
An open label randomized controlled trial on the preemptive risedronate intervention for glucocorticoid-induced osteoporosis in chronic kidney disease patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Sep 2013
Price :
$35
*
At a glance
- Drugs Risedronic acid (Primary) ; Vitamin D
- Indications Corticosteroid-induced osteoporosis
- Focus Therapeutic Use
- Acronyms PRIUS-CKD Study
- 06 Sep 2013 New trial record